SCHEMBL30120995

SCHEMBL30120995

ON=Cc1ccccc1C#CC1CCOCC1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.33
ALDH1A1 P00352 2/20 0.33
LMNA P02545 5/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
GSK3A P49840 1/20 0.32
GSK3B P49841 1/20 0.32
CDK5 Q00535 1/20 0.32
KMT2A Q03164 1/20 0.32
CDK5R1 Q15078 1/20 0.32
HTT P42858 3/20 0.31
TSHR P16473 2/20 0.31
FGF23 Q9GZV9 1/20 0.31
HAO1 Q9UJM8 2/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
MAPK1 P28482 1/20 0.31
HSD17B10 Q99714 1/20 0.31
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23887755 0.77 MAOB (0.39) HPGDALDH1A1MAPTKMT2AGAA
SCHEMBL30367984 0.77 MAOB (0.39) HPGDALDH1A1MAPTKMT2AGAA
SCHEMBL25195489 0.73 RAB9A (0.38) HPGDALDH1A1LMNAKDM4EMEN1
SCHEMBL23896349 0.73 RAB9A (0.38) HPGDALDH1A1LMNAKDM4EMEN1
SCHEMBL30121047 0.71 HAO1 (0.41) HPGDALDH1A1KDM4EMAPTHAO1
SCHEMBL23887737 0.69 RAB9A (0.39) HPGDALDH1A1LMNAKDM4EMEN1
SCHEMBL29958070 0.68 LMNA (0.43) HPGDALDH1A1LMNAMEN1MAPT
SCHEMBL30134875 0.68 LMNA (0.43) HPGDALDH1A1LMNAMEN1MAPT
SCHEMBL28789381 0.68 HAO1 (0.45) HPGDALDH1A1LMNAMEN1MAPT
SCHEMBL29798255 0.66 HPGD (0.43) HPGDALDH1A1LMNAMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126819-A1 7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1 -ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1 -ANTITRYPSIN DEFICIENCY (AATD) Vertex Pharmaceuticals Incorporated (US) 2023-02-08 EP disclosed